Fruquintinib(呋喹替尼胶囊)

Fruquintinib Capsules, featuring convenient oral administration, strong anti-angiogenic activity and good tolerance, serves as an effective later-line treatment option for patients.

1mg*7capsules
5mg*7capsules

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Fruquintinib Drug News

On September 5, 2018, the National Medical Products Administration (NMPA) approved the marketing of fruquintinib capsules (trade name: Elunate), a therapeutic drug for the treatment of metastatic colorectal cancer.

Fruquintinib Capsules, a Drug for Metastatic Colorectal Cancer, Approved for Marketing

September 5, 2018, the National Medical Products Administration (NMPA) approved the marketing of Fruquintinib Capsules (Elunate), a therapeutic drug f···【Read More】
Update: 26 Feb,2026Source: Haiou HealthViews: 105

Frist Prev 1 1/1 Next Last

Seagull Health·Chinese Medicines

Fruquintinib(呋喹替尼胶囊)

Fruquintinib Drug News

Recommended

Fruquintinib Capsules, a Drug for Metastatic Colorectal Cancer, Approved for Marketing